SCHEMBL16159696

SCHEMBL16159696

c1ccc(-n2c3cc(-c4cncc(-c5cnco5)c4)ccc3c3ccc(-c4cncc(-c5cnco5)c4)cc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
MAPK8 P45983 3/20 0.40
KDM4E B2RXH2 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
PKM P14618 2/20 0.38
NOTUM Q6P988 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAP4K4 O95819 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PTK2 Q05397 1/20 0.36
KEAP1 Q14145 1/20 0.35
HDAC4 P56524 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16159085 0.91 KMT2A (0.48) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL16159849 0.91 CYP11B1 (0.47) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL16159705 0.88 CYP11B1 (0.36) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL16159162 0.82 ROCK2 (0.42) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL16159624 0.82 CYP11B1 (0.45) CYP11B1CYP11B2L3MBTL1LMNAPKM
SCHEMBL16159241 0.80 ROCK2 (0.43) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL18101986 0.80 MEN1 (0.42) CYP11B1CYP11B2KDM4EATML3MBTL1
SCHEMBL16159086 0.79 KMT2A (0.40) CYP11B1CYP11B2MAPK8KDM4EATM
SCHEMBL16159902 0.79 CYP11B1 (0.51) CYP11B1CYP11B2KDM4ELMNAPKM
SCHEMBL16159855 0.79 MAPK8 (0.39) CYP11B1CYP11B2MAPK8KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC CORPORATION (JP) 2016-04-28 US disclosed
WO-2014163173-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME JNC株式会社 (JP) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118598-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME HVCN1, VDAC1, SLC26A3 CYP11B1 312/4885CYP11B2 420/4885MAPK8 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.